Percutaneous balloon dilatation is now a widely accepted treatment for pulmonary valve stenosis in children and adults.'2 Its application to the treatment of severe stenosis of the pulmonary valve in early infancy is less well established. There have been several reports of successful balloon dilatation in this age group. '7 The procedure is generally thought to be safe and effective, especially when the arterial duct is patent. When the arterial duct is closed, however, balloon dilatation may not be straightforward. The purpose of this paper is to highlight the complications associated with this procedure and to suggest modifications of technique for avoiding these complications.
Patients and methods
Percutaneous balloon dilatation was attempted for severe pulmonary valve stenosis in three neonates and infants. The group consisted of an 11 week old boy (born at 32 weeks' gestation) (case 1), a one week old boy (case 2), and a three week old girl (case 3) ( used to calculate the magnification factor. The arterial duct was closed in all three patients. The haemodynamic data are given in the table.
In case 1, a 5 French multipurpose end hole catheter was passed into the right ventricle. The patient remained haemodynamically stable while attempts were made to cross the pulmonary valve. Eventually, after the valve was crossed with a tip deflector wire in the catheter, the catheter was rapidly positioned in the proximal left pulmonary artery. The gradient across the pulmonary valve was 220 mm Hg. A 0-018 inch diameter floppy tipped exchange guide wire was quickly introduced through the catheter and placed in the distal left pulmonary artery. The patient developed rapidly progressive bradycardia and hypotension with pronounced ST segment depression on the electrocardiogram. The catheter was withdrawn to the right atrium, leaving the guide wire in the pulmonary artery, while external cardiac massage was started. Bradycardia persisted and so the guide wire was also removed. Subsequently, a stable cardiac rhythm was achieved but the infant remained hypotensive and hypoxic. An emergency Waterston shunt was performed, but he remained hypotensive and died three days later.
Necropsy confirmed severe pulmonary valve stenosis (figure) with a pulmonary valve orifice diameter of 1 5-2 mm (the external diameter of the catheter used was 1-7 mm). There was considerable hypertrophy of the right ventricle with muscular narrowing of the outflow tract. The arterial duct was closed.
After the complications encountered in case 
In case 3, a 4-2 mm diameter balloon catheter on 4 3 French shaft (Schneider-Medintage AG) was positioned across the pulmonary valve and the balloon was inflated several times. The balloon catheter was replaced by a 5 French end hole catheter and a 0-021 inch exchange guide wire was positioned in the distal left pulmonary artery. This allowed a 6 mm diameter balloon catheter on a 5 French shaft (Schneider-Medintag) to be placed across the valve and the inflations repeated. Subsequently, the balloon catheter was replaced by the 5 French end hole catheter and the guide wire by a 0 035 inch exchange guide wire. A balloon catheter of 10 mm diameter on a 7 French shaft (Schneider-Medintag) was advanced over the wire and the inflations repeated until the constriction of the pulmonary valve was abolished. Both the patients were electively ventilated after the procedure for 24-48 hours.
Results
In cases 2 and 3, the procedure was well tolerated with only transient hypoxia, bradycardia, and hypotension with each balloon dilatation. Four different sized balloons were used in case 2 and three in case 3.
At the end of the procedure, in case 2, the right ventricular systolic pressure was 45 mm Hg compared with the femoral artery systolic pressure of 90 mm Hg. The peak to peak systolic pressure gradient across the pulmonary valve was 15 mm Hg. In case 3, the pulmonary artery pressure was 25/13 mm Hg and the right ventricular systolic pressure was 125 mm Hg; the gradient across the right ventricular outflow (at infundibular level) was 100 mm Hg. The brachial artery systolic pressure was 95 mm Hg.
Case 2 was discharged home four days and case 3 two weeks after balloon dilatation. In case 3, serial Doppler studies showed a gradual reduction in the transvalvar gradient to 16 mm Hg before discharge.
At the latest follow up, in each patient eight months after balloon dilatation, both the infants were symptom free and thriving. Doppler ultrasound showed an estimated residual gradient across the pulmonary valve of 13 mm Hg in case 2 and 16 mm Hg in case 3.
Discussion
Balloon dilatation of the pulmonary valve for pulmonary valve stenosis is reported to be safe and effective in neonates, infants, and children.' The first case in this report shows the difficulties and potential hazards of passing a catheter through a severely stenosed pulmonary valve. In the early neonatal period a patent arterial duct provides an alternative source of pulmonary blood flow when the pulmonary valve orifice is occluded by a catheter or an inflated balloon. This may not be the case in the late neonatal period and early infancy, when the arterial duct has closed. It is in this group ofpatients that balloon dilatation may be less than straightforward. Nevertheless, the problems are not insurmountable and can be overcome by technical modifications.
Manoeuvring of the catheter across the severely narrowed pulmonary valve can prove difficult. In such patients, small diameter floppy guide wires are invaluable for the rapid placement ofthe wire and the catheter across the valve. Shortly after the catheter was placed in the pulmonary artery in case 1, the infant deteriorated haemodynamically. We believe that this was the result of total occlusion of the valve orifice by the catheter. Necropsy did not show any evidence of trauma to the outflow tract or pericardial tamponade. The orifice diameter of the pulmonary valve was similar to the external diameter of the catheter. The choice of the optimum treatment in this infant was difficult. In view of the severe right ventricular hypertension, a closed arterial duct and, in particular, the severe lung abnormalities, we considered it preferable to attempt percutaneous balloon dilatation rather than operation. It is debatable whether a surgical approach would have been advantageous.
Our experience with case 1 prompted us to modify our technique. In the next two cases the pulmonary valve was crossed with a 0-014 or 0-018 inch guide wire and an end hole catheter, usually of 4 French size, was only manoeuvred across the valve to help position the guide wire quickly in the distal left pulmonary artery and the catheter was then rapidly withdrawn to the right atrium, thus preventing any appreciable obstruction of the pulmonary blood flow. In both cases 2 and 3, we were unable to advance a 5 French end hole catheter through the pulmonary valve orifice. The first balloon inflation, we believe, is of crucial importance to the safety and the success of the rest of the procedure. We attempted dilatation initially with a smaller diameter (3 mm) coronary angioplasty or 4-2 mm diameter balloon catheter. This resulted in an increase in the valve orifice to effectively twice its original diameter, thus reducing the risks of compromising the pulmonary blood flow and facilitating the passage of subsequent balloon catheters. After this, we dilated the valve with balloon catheters of gradually increasing diameter.
It is conceivable that, in case 2, a satisfactory outcome could still have resulted with dilatation up to the 10 mm diameter (balloon to "annulus" ratio of 1-1) balloon rather than 13 mm (ratio 1 4), thus reducing the cost of the procedure. However, we set Qureshi, Ladusans, Martin out to achieve a final balloon to "annulus" ratio of 1 2-1 4. While a balloon to "annulus" ratio of < 1-0 may be effective initially, Rao reported that residual transvalvar gradients were significantly lower if the balloon to "annulus" ratio was > 1.0.8 Furthermore, even with a ratio of 1 0-12, recurrence ofpulmonary valve stenosis requiring repeat balloon dilatation was more likely than when the ratio was 1-2-1-4. In both cases 2 and 3 the excellent initial results have been maintained. In this age group, we found that progressive balloon dilatation was better than attempting to dilate the valve with one balloon 20-40% larger than the "annulus".
Our cases highlight the difficulties and complications associated with the management of severe stenosis ofthe pulmonary valve in early infancy when the arterial duct has closed. We believe that with attention to the technique and by using smaller floppy guide wires and smaller balloon catheters, of gradually increasing size, balloon dilatation can be safely and effectively performed in patients with severe pulmonary valve stenosis presenting in the late neonatal period and early infancy.
